Evidence map›Paper›PMID 39619349›Full record

ArticlePsychiatry and clinical psychopharmacology2021

Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Methamphetamine Use Disorder.

Bahadir Demir, Sengul Kocamer Sahin, Filiz Ozsoy, Abdurrahman Altindag, Gulcin Elboga

Abstract read
In one paragraph

Article in Psychiatry and clinical psychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Oxidative Stress and Inflammatory Biomarkers in People with Methamphetamine Use Disorder.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bahadir DemirDepartment of Psychiatry, Gaziantep University School of Medicine, Gaziantep, Turkey.ORCID 0000-0003-2798-6255
Sengul Kocamer SahinDepartment of Psychiatry, Gaziantep University School of Medicine, Gaziantep, Turkey.ORCID 0000-0002-5371-3907
Filiz OzsoyTokat State Hospital, Tokat, Turkey.ORCID 0000-0002-5198-8827
Abdurrahman AltindagDepartment of Psychiatry, Gaziantep University School of Medicine, Gaziantep, Turkey.ORCID 0000-0001-5531-4419
Gulcin ElbogaDepartment of Psychiatry, Gaziantep University School of Medicine, Gaziantep, Turkey.ORCID 0000-0003-3903-1835

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Methamphetamine (METH) is a potent central nervous system (CNS) stimulant that rapidly enhances the release of neurotransmitters, including adrenaline, dopamine, and serotonin. It is also one of the most popular illicit drugs of choice worldwide known as "ice". In this study, we examined the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) levels in patients with methamphetamine use disorder. Materials and Methods: This study included a total of 84 patients with only methamphetamine use and 81 healthy individuals. Participants who had hematological disorders and other chronic diseases were excluded from the study. White blood cell, neutrophil, lymphocyte, and platelet count were compared between groups. NLR and PLR values were calculated and compared between groups. Results: The patient group comprised 81 males and 3 females with the mean age of 26.37 ± 5.99 years. There was no significant difference between patient and control group in terms of age, sex, BMI, smoking status, and alcohol consumption. NLR and PLR ratios were lower in the patient group than controls. NLR and PLR values were positively correlated with daily dosage of METH use ( Conclusion: To the best of our knowledge, our study is the first study examining the relationship between NLR and PLR in patients with METH use disorder. NLR and PLR were found to be lower in patients with METH use disorder. The effects of METH on the immune system should be considered. Prospective, longitudinal studies involving intoxication-detoxification-remission periods are needed.

Indexed as

Lymphocytemethamphetamineneutrophilplateletsubstance

Identifiers

PMID39619349
PMCPMC11605309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.